Finding a good book to read on holiday may sometimes be a challenge. Luckily, the Open Pharma team is here to help with its shortlist of the best reads for summer 2019!
Open science is essential for medical research, says ABPI
The Association of the British Pharmaceutical Industry (ABPI) has said that it wants to take transparency to the next level, and has committed to making clinical research more accessible and understandable across the pharmaceutical industry.
What do preprints mean for medical publishing?
Preprints are all around us – but are they relevant and useful or too risky for industry-sponsored research? Two sessions at the 14th Annual Meeting of ISMPP held in Washington this month kicked off the first major public discussions on preprints in our medical communications community.
Open Pharma: a publisher’s perspective
We aimed to gain insight into the publishing industry’s perspective on new innovations in the field, as their collaboration will be key to implementing changes.
Why not use a novel publishing platform?
Questions from delegates at ISMPP US 2017 guided poster tour highlight practical issues presenting barriers to uptake of innovative platforms